• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

AIM The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …

Aims The effect of atrial fibrillation catheter ablation on cardiovascular outcomes in heart
failure is an important outstanding research question. We undertook a meta-analysis of …

Background The results of studies comparing the outcomes of catheter ablation (CA) to
those of medical therapy (MT) for atrial fibrillation (AF) in heart failure (HF) patients are …

Background Atrial fibrillation (AF) is common in heart failure (HF), is associated with worse
outcomes compared with sinus rhythm, and may modify the effects of therapy. Objectives …

Background: Atrial fibrillation (AF) and heart failure (HF) often coexist and synergistically
contribute to an increased risk of hospitalization, stroke, and mortality. Objective: To …

Catheter ablation (CA) of atrial fibrillation (AF) is the therapy of choice for the maintenance of
sinus rhythm in patients with symptomatic AF. Time towards interventional treatment and peri …

In the last three decades, ablation of atrial fibrillation (AF) has become an evidence-based
safe and efficacious treatment for managing the most common cardiac arrhythmia. In 2007 …

Atrial fibrillation (AF) is the most common sustained arrhythmia in hypertrophic
cardiomyopathy (HCM) with clinical and subclinical episodes occurring in nearly one-half of …

Introduction Increasing evidence has suggested improved outcomes in atrial fibrillation (AF)
patients with heart failure (HF) undergoing catheter ablation (CA) as compared to medical …